PROARRHYTHMIC EFFECTS OF THE CLASS-III AGENT ALMOKALANT - IMPORTANCE OF INFUSION RATE, QT DISPERSION, AND EARLY AFTERDEPOLARIZATIONS

被引:165
作者
CARLSSON, L
ABRAHAMSSON, C
ANDERSSON, B
DUKER, G
SCHILLERLINHARDT, G
机构
[1] Astra Hässle AB, Preclinical Research and Development, Cardiovascular Pharmacology
关键词
D O I
10.1093/cvr/27.12.2186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim was to study factors contributing to torsade de pointes in the acquired long QT syndrome. Methods: Anaesthetised rabbits or cats were given a continuous infusion of methoxamine and the class III agent almokalant (at a rate of 5 or 25 nmol.kg(-1).min(-1), respectively) and the effects on incidence of torsade de pointes and QT dispersion were examined. Effects of almokalant on action potentials recorded from Purkinje fibres and ventricular cells of rabbits and cats were also studied. Results: ''High rate'' infusion of almokalant prolonged the QT(c) interval [from 162(SEM 6.2) ms to 211(5.3) ms, p<0.001] and initiated torsade de pointes in 9/10 rabbits after a dose of 391(116.3) nmol.kg(-1). During ''low rate'' infusion, 1/8 rabbits developed torsade de pointes (p = 0.0029) despite infusion of 900 nmol.kg(-1) almokalant and QT(c) prolongation from 162(3.6) ms to 230(12.6) ms (p<0.01). In eight separate rabbits given the high rate infusion of almokalant, seven developed torsade de pointes and the QT(c) dispersion increased from 15(1.7) ms to 32(5.6) ms (p<0.05). In six rabbits given the low rate infusion, none developed torsade de pointes (p = 0.0023), and the QT(c) dispersion was unaltered. In six cats, high rate infusion induced a QT interval lengthening from 241(6.0) ms to 349(8.0) ms (p<0.001), but in only one cat was torsade de pointes initiated and preceded by a marked increase in QT dispersion (from 22 ms to 78 ms). In vitro, almokalant caused a marked lengthening of the action potential duration and early afterdepolarisations in Purkinje fibres but not in ventricular muscle cells of the rabbit. In the cat, however, almokalant induced a homogeneous prolongation of the action potential duration in both cell types, and early afterdepolarisations were never observed. Conclusions: The rate of infusion of repolarisation delaying agents may influence the dispersion of repolarisation and play a decisive role in the initiation of torsade de pointes.
引用
收藏
页码:2186 / 2193
页数:8
相关论文
共 38 条
[1]   ELECTROPHYSIOLOGICAL AND INOTROPIC EFFECTS OF H-234/09 (ALMOKALANT) INVITRO - A COMPARISON WITH 2 OTHER NOVEL-IK BLOCKING-DRUGS, UK-68,798 (DOFETILIDE) AND E-4031 [J].
ABRAHAMSSON, C ;
DUKER, G ;
LUNDBERG, C ;
CARLSSON, L .
CARDIOVASCULAR RESEARCH, 1993, 27 (05) :861-867
[3]  
BLACK SC, 1991, J PHARMACOL EXP THER, V258, P416
[4]   ALPHA-ADRENOCEPTORS AND ALPHA-ADRENOCEPTOR-MEDIATED POSITIVE INOTROPIC EFFECTS IN FAILING HUMAN MYOCARDIUM [J].
BOHM, M ;
DIET, F ;
FEILER, G ;
KEMKES, B ;
ERDMANN, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (03) :357-364
[5]  
BRACHMAN J, 1992, CIRCULATION, V28, P265
[6]   EARLY AFTERDEPOLARIZATIONS - ROLE IN CONDUCTION BLOCK, PROLONGED REPOLARIZATION-DEPENDENT REEXCITATION, AND TACHYARRHYTHMIAS IN THE HUMAN-HEART [J].
BRUGADA, P ;
WELLENS, HJJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1985, 8 (06) :889-896
[7]   QTU-PROLONGATION AND TORSADES-DE-POINTES INDUCED BY PUTATIVE CLASS-III ANTIARRHYTHMIC AGENTS IN THE RABBIT - ETIOLOGY AND INTERVENTIONS [J].
CARLSSON, L ;
ALMGREN, O ;
DUKER, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (02) :276-285
[8]   ANTIARRHYTHMIC EFFECTS OF POTASSIUM CHANNEL OPENERS IN RHYTHM ABNORMALITIES RELATED TO DELAYED REPOLARIZATION [J].
CARLSSON, L ;
ABRAHAMSSON, C ;
DREWS, L ;
DUKER, G .
CIRCULATION, 1992, 85 (04) :1491-1500
[9]   PROLONGED ACTION-POTENTIAL DURATION AND POSITIVE INOTROPY INDUCED BY THE NOVEL CLASS-III ANTIARRHYTHMIC AGENT H-234/09 (ALMOKALANT) IN ISOLATED HUMAN VENTRICULAR MUSCLE [J].
CARLSSON, L ;
ABRAHAMSSON, C ;
ALMGREN, O ;
LUNDBERG, C ;
DUKER, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (06) :882-887
[10]  
CARMELIET E, 1991, Journal of Molecular and Cellular Cardiology, V23, pS79, DOI 10.1016/0022-2828(91)90752-8